search
Back to results

TRE: Microbiome, Metabolic Health and Bone (TREMBO)

Primary Purpose

Weight Loss, Time Restricted Feeding, Bone Loss

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Time Restricted Eating (TRE)
Calorie Restriction
Sponsored by
Rutgers, The State University of New Jersey
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Weight Loss focused on measuring bone mineral density, Microbiome, obesity and overweight, metabolic health, time restricted feeding, energy restriction

Eligibility Criteria

50 Years - 79 Years (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Postmenopausal women (>2 years since last menses)
  • Body mass index (25-39 kg/m2)
  • Habitual consumption of food for at least 14 hours/day

Exclusion Criteria:

  • Participants with >5% weight loss in the past 6 months or extreme dietary/physical activity habits
  • An inability to follow the experimental intervention or to perform the required specimen collections
  • Antibiotic use in the past 6 months
  • Current diagnosis or history of cancer
  • History of surgical procedure for weight loss
  • Current diagnosis or history of bone diseases, type I or II diabetes, gastrointestinal disease, hyperparathyroidism, untreated thyroid disease, significant immune, hepatic, cardiac, or renal disease
  • Uncontrolled hypertension or hyperlipidemia in abnormal ranges
  • Regular use of medications that affect bone metabolism, including bisphosphonates or hormone replacement.
  • A colonoscopy within the past 2 months
  • Alcohol or illicit drug abuse
  • Current smoker or having quit smoking in the past 3 months
  • Shift work
  • Participation in another clinical research trial which may interfere with the results of this study.

Sites / Locations

  • Rutgers University - NJ Inst Food Nutrition & HealthRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Time restricted eating and calorie restriction

Calorie restriction alone

Arm Description

Subjects will be asked to adhere to a calorie-restricted diet and will be counseled by a dietitian for diet and lifestyle behavior education. In addition, they will be asked to only consume calories during a 9-hour window (15:9).

Subjects will be asked to adhere to a calorie-restricted diet and will be counseled by a dietitian for diet and lifestyle behavior education. They will be advised to continue to consume foods throughout the day and into the evening.

Outcomes

Primary Outcome Measures

Weight loss
Body weight in kg
Bone mineral density (BMD - hip)
dual energy x-ray absorptiometry
Microbiota
stool

Secondary Outcome Measures

Soft tissue (lean and fat mass)
dual energy x-ray absorptiometry
Areal BMD (lumbar spine, femoral neck, radius, total body)
dual energy x-ray absorptiometry
Trabecular bone (volumetric BMD, bone volume / total volume, and separation)
peripheral quantitative computed tomography
Cortical bone (volumetric BMD, thickness, and porosity) and total BMD
peripheral quantitative computed tomography
Blood pressure (systolic and diastolic)
sphygmomanometer
Glucose - response to oral glucose tolerance test
fasting and response to glucose solution
Insulin - response to oral glucose tolerance test
fasting and response to glucose solution

Full Information

First Posted
September 14, 2022
Last Updated
October 17, 2023
Sponsor
Rutgers, The State University of New Jersey
search

1. Study Identification

Unique Protocol Identification Number
NCT05548517
Brief Title
TRE: Microbiome, Metabolic Health and Bone
Acronym
TREMBO
Official Title
Time Restricted Eating on the Microbiome Affecting Metabolic Health and Bone in Older Women
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 15, 2022 (Actual)
Primary Completion Date
September 2024 (Anticipated)
Study Completion Date
September 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rutgers, The State University of New Jersey

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
In the Time-Restricted Eating: Microbiome and Bone (TREMBO) study, the primary goal is to determine the effect of time-restricted eating with caloric restriction compared to caloric restriction alone on body weight, the gut microbiota, and bone health in older women who are overweight or obese.
Detailed Description
Time-restricted eating (TRE) has gained increased attention due to the possibility to induce weight loss and improve cardiometabolic health as a result of the purported alignment of circadian rhythm. However, since TRE is often reported to cause a spontaneous reduction of calories, it is not well understood if these health benefits are due to weight loss, circadian rhythm alignment, or a combination of the two. Furthermore, while weight loss can improve cardiometabolic health, it can also induce bone loss, which is problematic in older women who are at a higher risk of fracture. Interestingly, both bone turnover and the gut microbiota are responsive to diurnal variations, such as meal timing, and alterations in the gut microbiota have been associated with differences in bone health. In rodent models, caloric restriction can alter the gut microbiota composition with further alterations shown due to time-restricted eating. This suggests that time-restricted eating could affect bone health, which may be partially mediated by changes in the gut microbiota. Also, lifestyle patterns affects both the microbiota and bone. This randomized controlled trial will use behavior modification to examine TRE plus caloric restriction (CR) to achieve an evening energy deficit compared to CR alone on body weight, the gut microbiota, and bone health in older women who are overweight or obese.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Weight Loss, Time Restricted Feeding, Bone Loss
Keywords
bone mineral density, Microbiome, obesity and overweight, metabolic health, time restricted feeding, energy restriction

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized Controlled Trial Enroll 48 to achieve sample size of 40 (20/group)
Masking
None (Open Label)
Allocation
Randomized
Enrollment
48 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Time restricted eating and calorie restriction
Arm Type
Experimental
Arm Description
Subjects will be asked to adhere to a calorie-restricted diet and will be counseled by a dietitian for diet and lifestyle behavior education. In addition, they will be asked to only consume calories during a 9-hour window (15:9).
Arm Title
Calorie restriction alone
Arm Type
Active Comparator
Arm Description
Subjects will be asked to adhere to a calorie-restricted diet and will be counseled by a dietitian for diet and lifestyle behavior education. They will be advised to continue to consume foods throughout the day and into the evening.
Intervention Type
Behavioral
Intervention Name(s)
Time Restricted Eating (TRE)
Intervention Description
9-hour eating window
Intervention Type
Behavioral
Intervention Name(s)
Calorie Restriction
Intervention Description
daily calorie restriction
Primary Outcome Measure Information:
Title
Weight loss
Description
Body weight in kg
Time Frame
change from baseline to an average 6 months
Title
Bone mineral density (BMD - hip)
Description
dual energy x-ray absorptiometry
Time Frame
change from baseline to an average 6 months
Title
Microbiota
Description
stool
Time Frame
change from baseline to an average 6 months
Secondary Outcome Measure Information:
Title
Soft tissue (lean and fat mass)
Description
dual energy x-ray absorptiometry
Time Frame
change from baseline to an average 6 months
Title
Areal BMD (lumbar spine, femoral neck, radius, total body)
Description
dual energy x-ray absorptiometry
Time Frame
change from baseline to an average 6 months
Title
Trabecular bone (volumetric BMD, bone volume / total volume, and separation)
Description
peripheral quantitative computed tomography
Time Frame
change from baseline to an average 6 months
Title
Cortical bone (volumetric BMD, thickness, and porosity) and total BMD
Description
peripheral quantitative computed tomography
Time Frame
change from baseline to an average 6 months
Title
Blood pressure (systolic and diastolic)
Description
sphygmomanometer
Time Frame
change from baseline to an average 6 months
Title
Glucose - response to oral glucose tolerance test
Description
fasting and response to glucose solution
Time Frame
change from baseline to an average 6 months
Title
Insulin - response to oral glucose tolerance test
Description
fasting and response to glucose solution
Time Frame
change from baseline to an average 6 months
Other Pre-specified Outcome Measures:
Title
25-hydroxyvitamin D (25OHD)
Description
serum
Time Frame
change from baseline to an average 6 months
Title
estradiol
Description
serum
Time Frame
change from baseline to an average 6 months
Title
parathyroid hormone (PTH)
Description
serum
Time Frame
change from baseline to an average 6 months
Title
Fasting osteocalcin
Description
serum bone formation and energy marker
Time Frame
change from baseline to an average 6 months
Title
Fasting procollagen type 1 N-terminal propeptide (PINP)
Description
serum bone formation marker
Time Frame
change from baseline to an average 6 months
Title
Fasting C-telopeptide of type I collagen (CTX)
Description
serum bone resorption marker
Time Frame
change from baseline to an average 6 months
Title
Cognitive function
Description
Cambridge Neuropsychological Test Automated Battery
Time Frame
change from baseline to an average 6 months
Title
melatonin
Description
serum
Time Frame
change from baseline to an average 6 months
Title
cortisol
Description
serum
Time Frame
change from baseline to an average 6 months
Title
Quality of sleep
Description
Pittsburgh sleep quality index (0-21; higher score is worse)
Time Frame
change from baseline to an average 6 months
Title
Diet quality score
Description
nutrient analysis software (Healthy Eating Index 0-100; higher score is better)
Time Frame
change from baseline to an average 6 months
Title
Eating self-efficacy
Description
Weight lifestyle efficacy questionnaire short-form (0-80; higher score is better)
Time Frame
change from baseline to an average 6 months
Title
Circumferences
Description
tape measure (waist, hip and thigh)
Time Frame
change from baseline to an average 6 months
Title
Short physical performance battery (SPPB)
Description
Total score of SPPB (0-12; higher score is better)
Time Frame
change from baseline to an average 6 months
Title
6 minute walk test
Description
total distance
Time Frame
change from baseline to an average 6 months
Title
Timed up and go
Description
total time
Time Frame
change from baseline to an average 6 months
Title
Hand Grip
Description
dynanometer (isometric grip force)
Time Frame
change from baseline to an average 6 months

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
Women
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
79 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Postmenopausal women (>2 years since last menses) Body mass index (25-45 kg/m2) Agree to be randomly assigned to consume food for ≤ 9 hours/day or ≥12 hours/day Must attend on-site visits (about 10) in New Brunswick, NJ, USA (transportation/reimbursement for travel not included) Exclusion Criteria: Participants with >5% weight loss in the past 6 months or extreme dietary/physical activity habits An inability to follow the experimental intervention or to perform the required specimen collections Antibiotic use in the past 2 months Current diagnosis, or history of cancer in past 3 years History of surgical procedure for weight loss in the past 3 years Current diagnosis or history of bone diseases, type I or II diabetes, gastrointestinal disease, hyperparathyroidism, untreated thyroid disease, significant immune, hepatic, cardiac, or renal disease Uncontrolled hypertension or hyperlipidemia in abnormal ranges Regular use of medications that affect bone metabolism, including bisphosphonates or hormone replacement. A colonoscopy within the past 2 months Alcohol or illicit drug abuse Current smoker or having quit smoking in the past 3 months Shift work Participation in another clinical research trial which may interfere with the results of this study.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Prinicipal Investigator
Phone
848-932-9403
Email
shapses@rutgers.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Brandon McGuire
Phone
732-743-5793
Email
RUWtloss@gmail.com
Facility Information:
Facility Name
Rutgers University - NJ Inst Food Nutrition & Health
City
New Brunswick
State/Province
New Jersey
ZIP/Postal Code
08901
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sue A Shapses
Phone
848-932-9403
Email
shapses@rutgers.edu

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

TRE: Microbiome, Metabolic Health and Bone

We'll reach out to this number within 24 hrs